Improvement in the heterogeneous N-termini and the defective N-glycosylation of human interleukin-6 by genetic engineering

Eur J Biochem. 1992 Nov 15;210(1):9-12. doi: 10.1111/j.1432-1033.1992.tb17384.x.

Abstract

Recombinant human interleukin-6 (IL-6), expressed in Chinese hamster ovary cells, has heterogeneous N-termini of Ala1 and Val3, as does naturally occurring IL-6. This heterogeneity is thought to be caused by difficulty in cleavage of the signal sequence. To obtain homogeneous IL-6, Pro at -1 was exchanged for Ala by site-directed mutagenesis. Alternatively, the signal sequence was replaced with that of human granulocyte-colony-stimulating factor. In both cases, the IL-6 designed to start with Ala1 was still heterogeneous, while the IL-6 designed to start with Val3 showed a homogeneous N-terminus. It is suggested that the heterogeneity of the N-terminus is caused not only by the signal sequence, but also by the succeeding sequences of the mature protein. Only a portion of recombinant human IL-6 is N-glycosylated. Asn46, being exchanged for Gln by site-directed mutagenesis, was confirmed to be partially N-glycosylated. The defective N-glycosylation was assumed to be caused by interference or tension from a disulfide bond near the N-glycosylation site. To verify this hypothesis, the Cys45 and Cys51 forming the disulfide bond were exchanged for Ser. The N-glycosylated species became predominant upon this substitution, suggesting that formation of the disulfide bond is a cause of the defective N-glycosylation.

MeSH terms

  • Amino Acid Sequence
  • Animals
  • Base Sequence
  • CHO Cells
  • Cricetinae
  • DNA
  • Glycosylation
  • Humans
  • Interleukin-6 / genetics
  • Interleukin-6 / metabolism*
  • Molecular Sequence Data
  • Mutagenesis, Site-Directed
  • Plasmids
  • Protein Structure, Secondary
  • Recombinant Proteins / genetics
  • Recombinant Proteins / metabolism

Substances

  • Interleukin-6
  • Recombinant Proteins
  • DNA